08/01/2008
Patrick W. Serruys, MD, PhD; Sjoerd H. Hofma, MD; Eugene P. McFadden, MB, MD; Georgios Sianos, MD, PhD; Pieter C. Smits, MD, PhD; Willem J. van der Giessen, MD, PhD; Pim J. de Feyter, MD, PhD; Ron T. van Domburg, PhD; Jiro Aoki, MD; Gaston A. Alfredo Rodriguez-Granillo, MD; Andrew T.L. Ong, MD, MBBS, PhD; Maniyal Vijayakumar; Angela Hoye, MB, MRCP, MD, MBChB; Pedro A. Lemos, MD
Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...
Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...
Ostial atherosclerotic lesions...
